Technology All Share
4.073,12
PKT
+35,50
PKT
+0,88
%
Werbung
Analysen zu Technology All Share-Werten
Datum | Rating | Analyst | |
---|---|---|---|
15.01.24 | Bechtle Buy | Baader Bank | |
15.01.24 | MorphoSys Overweight | JP Morgan Chase & Co. | |
15.01.24 | Nordex Neutral | Goldman Sachs Group Inc. | |
15.01.24 | EVOTEC Sector Perform | RBC Capital Markets | |
12.01.24 | Nordex Buy | Deutsche Bank AG | |
12.01.24 | CANCOM Hold | Deutsche Bank AG | |
12.01.24 | Bechtle Buy | Deutsche Bank AG | |
12.01.24 | Bechtle Buy | Baader Bank | |
12.01.24 | Drägerwerk Buy | Warburg Research | |
11.01.24 | EVOTEC Sector Perform | RBC Capital Markets | |
11.01.24 | Carl Zeiss Meditec Buy | UBS AG | |
10.01.24 | Carl Zeiss Meditec Buy | UBS AG | |
10.01.24 | freenet Buy | Hauck & Aufhäuser Privatbankiers KGaA | |
10.01.24 | AIXTRON Buy | Jefferies & Company Inc. | |
10.01.24 | AIXTRON Overweight | Barclays Capital | |
09.01.24 | AIXTRON Buy | Jefferies & Company Inc. | |
09.01.24 | Drägerwerk Underperform | Jefferies & Company Inc. | |
09.01.24 | ATOSS Software Hold | Jefferies & Company Inc. | |
09.01.24 | AIXTRON Sell | UBS AG | |
09.01.24 | Carl Zeiss Meditec Buy | Hauck & Aufhäuser Privatbankiers KGaA | |
08.01.24 | United Internet Neutral | UBS AG | |
08.01.24 | Elmos Semiconductor Buy | Hauck & Aufhäuser Privatbankiers KGaA | |
08.01.24 | Bechtle Buy | Warburg Research | |
08.01.24 | QIAGEN Overweight | Morgan Stanley | |
08.01.24 | EVOTEC Sector Perform | RBC Capital Markets | |
08.01.24 | Carl Zeiss Meditec Buy | UBS AG | |
05.01.24 | Elmos Semiconductor Buy | Warburg Research | |
05.01.24 | EVOTEC Hold | Deutsche Bank AG | |
05.01.24 | QIAGEN Neutral | UBS AG | |
04.01.24 | Nemetschek Equal Weight | Barclays Capital | |
04.01.24 | EVOTEC Buy | Warburg Research | |
04.01.24 | Sartorius vz. Hold | Deutsche Bank AG | |
04.01.24 | AIXTRON Sell | UBS AG | |
04.01.24 | AIXTRON Sell | UBS AG | |
04.01.24 | EVOTEC Sector Perform | RBC Capital Markets | |
03.01.24 | QIAGEN Neutral | UBS AG | |
03.01.24 | Eckert Ziegler Buy | Hauck & Aufhäuser Privatbankiers KGaA | |
02.01.24 | MorphoSys Overweight | JP Morgan Chase & Co. | |
02.01.24 | Sartorius vz. Overweight | JP Morgan Chase & Co. | |
22.12.23 | Carl Zeiss Meditec Neutral | UBS AG |